You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PF

Showing 1 - 25 of 4,694
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Jun 7, 2023

Helathy Trial (PF-07328948, Placebo)

Not yet recruiting
  • Helathy
  • (no location specified)
Mar 29, 2023

Healthy Participants Trial (Single dose of PF-07220060 as first Tablet Formulation, Single dose of PF-07220060 as second Tablet

Not yet recruiting
  • Healthy Participants
  • Single dose of PF-07220060 as first Tablet Formulation
  • +3 more
  • (no location specified)
Jun 20, 2023

Atopic Dermatitis Trial in United States (PF-07275315, PF-07264660, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • Huntington Beach, California
  • +3 more
Aug 21, 2023

Pulmonary Arterial Hypertension Trial (PF-07868489, Placebo for PF-07868489)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • (no location specified)
Nov 14, 2023

Healthy Trial in New Haven (PF-06821497 Treatment A, PF-06821497 Treatment B, PF-06821497 Treatment C)

Not yet recruiting
  • Healthy
  • PF-06821497 Treatment A
  • +5 more
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Mar 17, 2023

Healthy Trial (PF-07976016, Placebo, Midazolam)

Not yet recruiting
  • Healthy
  • (no location specified)
Oct 24, 2023

Dry Eye Trial in Fort Worth (Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF), Polyethylene

Not yet recruiting
  • Dry Eye
  • Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF)
  • Polyethylene glycol 400 and propylene glycol solution/drops - Preserved
  • Fort Worth, Texas
    Alcon Call Center for Trial Locations
Jul 6, 2023

Healthy Trial (Drug: PF-07817883)

Not yet recruiting
  • Healthy
  • Drug: PF-07817883
  • (no location specified)
Nov 2, 2023

Healthy Trial (PF-07817883, Itraconazole)

Not yet recruiting
  • Healthy
  • (no location specified)
Apr 10, 2023

Renal Impairment Trial (Drug: PF-07923568)

Not yet recruiting
  • Renal Impairment
  • Drug: PF-07923568
  • (no location specified)
Sep 7, 2023

Healthy Participants Trial in Groningen (Oral [14C]PF-07081532, Oral PF-07081532 and IV [14C]PF-07081532)

Recruiting
  • Healthy Participants
  • Oral [14C]PF-07081532
  • Oral PF-07081532 and IV [14C]PF-07081532
  • Groningen, Netherlands
    PRA Health Sciences
Jan 5, 2023

Healthy Participants Trial (PF-07293893, Placebo)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Jun 8, 2023

Breast Cancer, Solid Tumors Trial in Boston, Grand Rapids, Houston (PF-07220060 + PF-07104091 combination dose escalation,

Recruiting
  • Breast Cancer
  • Solid Tumors
  • PF-07220060 + PF-07104091 combination dose escalation
  • +2 more
  • Grand Rapids, Michigan
  • +1 more
Jun 28, 2022

Overweight, Obesity Trial in New Haven (Formulation A (PF-07081532 20 mg plus 60 mg), Formulation B (PF-07081532 80 mg))

Recruiting
  • Overweight
  • Obesity
  • Formulation A (PF-07081532 20 mg plus 60 mg)
  • Formulation B (PF-07081532 80 mg)
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 25, 2023

Healthy Participants Trial in New Haven, Brussels (PF-07321332 Dose 1, PF-07321332 Dose 2, PF-07321332 Dose 3)

Completed
  • Healthy Participants
  • PF-07321332 Dose 1
  • +5 more
  • New Haven, Connecticut
  • +1 more
Sep 8, 2022

Healthy Participants Trial (PF-07853578, Placebo)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
May 25, 2023

Healthy Participants Trial in Brussels (PF-07899895, Placebo)

Not yet recruiting
  • Healthy Participants
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Pfizer Clinical Research Unit - Brussels
Nov 14, 2023

Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous Trial (Placebo, PF-06823859)

Not yet recruiting
  • Lupus Erythematosus, Systemic
  • Lupus Erythematosus, Cutaneous
  • (no location specified)
May 18, 2023

COVID-19 Trial (PF-07817883)

Not yet recruiting
  • COVID-19
  • (no location specified)
May 23, 2023

Healthy Trial (Dabigatran etexilate (DE), Rosuvastatin, PF-07081532)

Not yet recruiting
  • Healthy
  • Dabigatran etexilate (DE)
  • +2 more
  • (no location specified)
Mar 15, 2023

Healthy Participants Trial in New Haven (PF-06954522, Placebo)

Not yet recruiting
  • Healthy Participants
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Aug 15, 2023

SARS-CoV-2 Infection Trial (PF-07817883, Placebo)

Not yet recruiting
  • SARS-CoV-2 Infection
  • (no location specified)
Apr 4, 2023

Healthy Trial in New Haven (PF-07295324, PF-07259955)

Active, not recruiting
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Aug 3, 2022

Healthy Trial in New Haven, Brussels (PF-07817883, Placebo, Midazolam)

Recruiting
  • Healthy
  • New Haven, Connecticut
  • +1 more
Dec 19, 2022